logo

Harpoon Therapeutics Inc. (HARP)



Trade HARP now with
  Date
  Headline
7/2/2020 7:39:53 AM Harpoon Therapeutics Appoints Joanne Viney To Its Board
5/22/2020 7:36:38 AM Harpoon To Present Interim Clinical Data For TriTAC HPN424 At ASCO20 Virtual Scientific Program
4/27/2020 6:35:34 AM Harpoon Says First Patient Dosed With HPN217 In Phase 1/2 Clinical Trial
4/27/2020 6:34:01 AM Harpoon Therapeutics Doses First Patient With HPN217 For Multiple Myeloma
4/1/2020 7:34:29 AM Harpoon Therapeutics Names Andrew Robbins And Joseph Bailes To Board
8/6/2019 9:31:48 AM Wedbush Is Raising Harpoon Therapeutics Inc. (HARP) FY21 Estimate To -2.67 From -3.35
8/6/2019 9:31:35 AM Wedbush Is Increasing Harpoon Therapeutics Inc. (HARP) Q4 21 Estimate To -0.71 From -0.88
8/6/2019 9:31:21 AM Wedbush Is Raising Harpoon Therapeutics Inc. (HARP) Q3 21 Estimate To -0.68 From -0.85
8/6/2019 9:31:04 AM Wedbush Is Increasing Harpoon Therapeutics Inc. (HARP) Q2 21 Estimate To -0.66 From -0.82
8/6/2019 9:30:51 AM Wedbush Is Increasing Harpoon Therapeutics Inc. (HARP) Q1 21 Estimate To -0.63 From -0.79
8/6/2019 8:57:41 AM Wedbush Is Raising Harpoon Therapeutics Inc. (HARP) FY20 Estimate To -2.72 From -3.13
8/6/2019 8:57:23 AM Wedbush Is Increasing Harpoon Therapeutics Inc. (HARP) Q4 20 Estimate To -0.61 From -0.75
8/6/2019 8:56:40 AM Wedbush Is Increasing Harpoon Therapeutics Inc. (HARP) Q3 20 Estimate To -0.77 From -0.86
8/6/2019 8:56:26 AM Wedbush Is Increasing Harpoon Therapeutics Inc. (HARP) Q2 20 Estimate To -0.70 From -0.79
8/6/2019 8:56:12 AM Wedbush Is Increasing Harpoon Therapeutics Inc. (HARP) Q1 20 Estimate To -0.65 From -0.73
8/6/2019 8:55:58 AM Wedbush Is Raising Harpoon Therapeutics Inc. (HARP) FY19 Estimate To -2.56 From -2.79